Envía el siguiente mensaje a través de WhatsApp
Ir al chathttps://www.marketscreener.com/quote/stock/INDEX-PHARMACEUTICALS-HOL-39436573/news/InDex-Pharmaceuticals-receives-FDA-clearance-to-start-the-phase-III-study-CONCLUDE-with-cobitolimo-36231982/?utm_source=whatsapp&utm_medium=social&utm_campaign=share